The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

Starr, 2003, Positive and negative selection of T cells, Annu Rev Immunol, 21, 139, 10.1146/annurev.immunol.21.120601.141107

Zhang, 1994, Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis, J Exp Med, 179, 973, 10.1084/jem.179.3.973

Markovic-Plese, 1995, T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans, J Immunol, 155, 982, 10.4049/jimmunol.155.2.982

Fossiez, 1996, T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, J Exp Med, 183, 2593, 10.1084/jem.183.6.2593

Constant, 1997, Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches, Annu Rev Immunol, 15, 297, 10.1146/annurev.immunol.15.1.297

Nelms, 1999, The IL-4 receptor: signaling mechanisms and biologic functions, Annu Rev Immunol, 17, 701, 10.1146/annurev.immunol.17.1.701

Gately, 1998, The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses, Annu Rev Immunol, 16, 495, 10.1146/annurev.immunol.16.1.495

Szabo, 2000, A novel transcription factor, T-bet, directs Th1 lineage commitment, Cell, 100, 655, 10.1016/S0092-8674(00)80702-3

Szabo, 2002, Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells, Science, 295, 338, 10.1126/science.1065543

Zheng, 1997, The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells, Cell, 89, 587, 10.1016/S0092-8674(00)80240-8

Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunol, 4, 330, 10.1038/ni904

Wan, 2005, Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter, Proc Natl Acad Sci USA, 102, 5126, 10.1073/pnas.0501701102

Ivanov, 2006, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035

Liblau, 1995, Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases, Immunol Today, 16, 34, 10.1016/0167-5699(95)80068-9

Matthys, 1998, Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice, Eur J Immunol, 28, 2143, 10.1002/(SICI)1521-4141(199807)28:07<2143::AID-IMMU2143>3.0.CO;2-C

Ferber, 1996, Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE), J Immunol, 156, 5

Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753

Veldhoen, 2006, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001

Mangan, 2006, Transforming growth factor-beta induces development of the T (H) 17 lineage, Nature, 441, 231, 10.1038/nature04754

Lubberts, 2002, Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction, Inflamm Res, 51, 102, 10.1007/BF02684010

Langrish, 2005, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, 201, 233, 10.1084/jem.20041257

Weaver, 2006, Th17: an effector CD4 T cell lineage with regulatory T cell ties, Immunity, 24, 677, 10.1016/j.immuni.2006.06.002

Rouvier, 1993, CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene, J Immunol, 150, 5445

Yao, 1996, Complete nucleotide sequence of the mouse CTLA8 gene, Gene, 168, 223, 10.1016/0378-1119(95)00778-4

Li, 2000, Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family, Proc Natl Acad Sci USA, 97, 773, 10.1073/pnas.97.2.773

Starnes, 2002, Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis, J Immunol, 169, 642, 10.4049/jimmunol.169.2.642

Lee, 2001, IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1, J Biol Chem, 276, 1660, 10.1074/jbc.M008289200

Starnes, 2001, Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production, J Immunol, 167, 4137, 10.4049/jimmunol.167.8.4137

Shi, 2000, A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity, J Biol Chem, 275, 19167, 10.1074/jbc.M910228199

Yao, 1995, Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor, Immunity, 3, 811, 10.1016/1074-7613(95)90070-5

Ferretti, 2003, IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger, J Immunol, 170, 2106, 10.4049/jimmunol.170.4.2106

Lockhart, 2006, IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection, J Immunol, 177, 4662, 10.4049/jimmunol.177.7.4662

Shin, 1999, Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway, Cytokine, 11, 257, 10.1006/cyto.1998.0433

Molet, 2001, IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines, J Allergy Clin Immunol, 108, 430, 10.1067/mai.2001.117929

Zhou, 2005, Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein, Infect Immun, 73, 935, 10.1128/IAI.73.2.935-943.2005

Yao, 1997, Molecular characterization of the human interleukin (IL)-17 receptor, Cytokine, 9, 794, 10.1006/cyto.1997.0240

Silva, 2003, The profile of gene expression of human marrow mesenchymal stem cells, Stem Cells, 21, 661, 10.1634/stemcells.21-6-661

Haudenschild, 2002, Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer, J Biol Chem, 277, 4309, 10.1074/jbc.M109372200

Moseley, 2003, Interleukin-17 family and IL-17 receptors, Cytokine Growth Factor Rev, 14, 155, 10.1016/S1359-6101(03)00002-9

Ye, 2001, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense, J Exp Med, 194, 519, 10.1084/jem.194.4.519

Nakae, 2002, Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses, Immunity, 17, 375, 10.1016/S1074-7613(02)00391-6

Attur, 1997, Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage, Arthritis Rheum, 40, 1050, 10.1002/art.1780400609

Ruddy, 2004, Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members, J Biol Chem, 279, 2559, 10.1074/jbc.M308809200

Albanesi, 1999, IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha, J Immunol, 162, 494

Witowski, 2000, IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells, J Immunol, 165, 5814, 10.4049/jimmunol.165.10.5814

Woltman, 2000, Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells, J Am Soc Nephrol, 11, 2044, 10.1681/ASN.V11112044

Miyamoto, 2003, Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways, J Immunol, 170, 4665, 10.4049/jimmunol.170.9.4665

Ye, 2001, Interleukin-17 and lung host defense against Klebsiella pneumoniae infection, Am J Respir Cell Mol Biol, 25, 335, 10.1165/ajrcmb.25.3.4424

Laan, 2001, IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases, Br J Pharmacol, 133, 200, 10.1038/sj.bjp.0704063

Jones, 2002, Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells, Am J Respir Cell Mol Biol, 26, 748, 10.1165/ajrcmb.26.6.4757

Yao, 1995, Human IL-17: a novel cytokine derived from T cells, J Immunol, 155, 5483

McGeachy, 2005, Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis, Cytokine, 32, 81, 10.1016/j.cyto.2005.07.012

Lubberts, 2005, The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models, Arthritis Res Ther, 7, 29, 10.1186/ar1478

Schwarzenberger, 1998, IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines, J Immunol, 161, 6383

Pan, 2001, Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice, J Immunol, 167, 6559, 10.4049/jimmunol.167.11.6559

Miossec, 2003, Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy, Arthritis Rheum, 48, 594, 10.1002/art.10816

Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J Clin Invest, 103, 1345, 10.1172/JCI5703

Hwang, 2005, Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients, Mol Cells, 19, 180

Chabaud, 1999, Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, Arthritis Rheum, 42, 963, 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E

Chabaud, 2001, IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis, Arthritis Res, 3, 168, 10.1186/ar294

Chabaud, 1998, Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines, J Immunol, 161, 409

Katz, 2001, Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a ‘fine–tuning cytokine’ in inflammation processes, Arthritis Rheum, 44, 2176, 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4

LeGrand, 2001, Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci, Arthritis Rheum, 44, 2078, 10.1002/1529-0131(200109)44:9<2078::AID-ART358>3.0.CO;2-J

Lubberts, 2000, Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4, Arthritis Rheum, 43, 1300, 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D

Jovanovic, 2001, Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages, J Rheumatol, 28, 712

Jovanovic, 2000, Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis, Arthritis Rheum, 43, 1134, 10.1002/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO;2-#

Chabaud, 2000, Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, Cytokine, 12, 1092, 10.1006/cyto.2000.0681

Chevrel, 2002, Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation, Ann Rheum Dis, 61, 730, 10.1136/ard.61.8.730

Van bezooijen, 1999, Interleukin-17: a new bone acting cytokine in vitro, J Bone Miner Res, 14, 1513, 10.1359/jbmr.1999.14.9.1513

Chabaud, 2001, Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines, J Immunol, 167, 6015, 10.4049/jimmunol.167.10.6015

Nakae, 2003, IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist, Proc Natl Acad Sci USA, 100, 5986, 10.1073/pnas.1035999100

Nakae, 2003, Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice, J Immunol, 171, 6173, 10.4049/jimmunol.171.11.6173

Hoshino, 2000, Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo, J Allergy Clin Immunol, 105, 143, 10.1016/S0091-6749(00)90189-1

Happel, 2003, Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection, J Immunol, 170, 4432, 10.4049/jimmunol.170.9.4432

Laan, 1999, Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways, J Immunol, 162, 2347

Kawaguchi, 2001, Modulation of bronchial epithelial cells by IL-17, J Allergy Clin Immunol, 108, 804, 10.1067/mai.2001.119027

Rahman, 2006, IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, P38) pathways, J Immunol, 177, 4064, 10.4049/jimmunol.177.6.4064

Laan, 2002, Free, soluble interleukin-17 protein during severe inflammation in human airways, Eur Respir J, 19, 534, 10.1183/09031936.02.00280902

Barczyk, 2003, Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine, Respir Med, 97, 726, 10.1053/rmed.2003.1507

Hellings, 2003, Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma, Am J Respir Cell Mol Biol, 28, 42, 10.1165/rcmb.4832

Jatakanon, 1999, Neutrophilic inflammation in severe persistent asthma, Am J Respir Crit Care Med, 160, 1532, 10.1164/ajrccm.160.5.9806170

Bank, 1995, Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release, Inflammation, 19, 83, 10.1007/BF01534383

Skold, 1999, Human neutrophil elastase augments fibroblast-mediated contraction of released collagen gels, Am J Respir Crit Care Med, 159, 1138, 10.1164/ajrccm.159.4.9805033

Suzuki, 1996, Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor, Am J Respir Crit Care Med, 153, 1405, 10.1164/ajrccm.153.4.8616573

Bank, 1999, Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation, FEBS Lett, 461, 235, 10.1016/S0014-5793(99)01466-0

Chen, 2003, Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop, J Biol Chem, 278, 17036, 10.1074/jbc.M210429200

Merville, 1993, Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversibly rejected human kidney allografts, and their modulation by IL-2 and IL-4, Transplantation, 55, 639, 10.1097/00007890-199303000-00032

Merville, 1993, Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4, Transplant Proc, 25, 111

Pavlakis, 1996, Intragraft IL-15 transcripts are increased in human renal allograft rejection, Transplantation, 62, 543, 10.1097/00007890-199608270-00020

Loong, 2002, Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection, J Pathol, 197, 322, 10.1002/path.1117

Van, 1998, Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection, J Am Soc Nephrol, 9, 1526, 10.1681/ASN.V981526

Hsieh, 2002, Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells, Cytokine, 19, 159, 10.1006/cyto.2002.1952

Vanaudenaerde, 2006, The role of interleukin-17 during acute rejection after lung transplantation, Eur Respir J, 27, 779, 10.1183/09031936.06.00019405

Yoshida, 2006, Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants, Am J Transplant, 6, 724, 10.1111/j.1600-6143.2006.01236.x

Li, 2006, Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model, Eur J Cardiothorac Surg, 29, 779, 10.1016/j.ejcts.2006.01.052

Tang, 2001, Interleukin-17 antagonism inhibits acute but not chronic vascular rejection, Transplantation, 72, 348, 10.1097/00007890-200107270-00035

Antonysamy, 1999, Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors, J Immunol, 162, 577

Wong, 2000, Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus, Lupus, 9, 589, 10.1191/096120300678828703

Arican, 2005, Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity, Mediat Inflammation, 2005, 273, 10.1155/MI.2005.273

Homey, 2000, Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis, J Immunol, 164, 6621, 10.4049/jimmunol.164.12.6621

Matusevicius, 1999, Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, Mult Scler, 5, 101, 10.1177/135245859900500206

Kurasawa, 2000, Increased interleukin-17 production in patients with systemic sclerosis, Arthritis Rheum, 43, 2455, 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K

Fujino, 2003, Increased expression of interleukin 17 in inflammatory bowel disease, Gut, 52, 65, 10.1136/gut.52.1.65

Biesinger, 1992, Stable growth transformation of human T lymphocytes by herpesvirus saimiri, Proc Natl Acad Sci USA, 89, 3116, 10.1073/pnas.89.7.3116

Patera, 2002, Interleukin 17 modulates the immune response to vaccinia virus infection, Virology, 299, 56, 10.1006/viro.2002.1400

Knappe, 1998, The interleukin-17 gene of herpesvirus saimiri, J Virol, 72, 5797, 10.1128/JVI.72.7.5797-5801.1998

Luzza, 2000, Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa, J Immunol, 165, 5332, 10.4049/jimmunol.165.9.5332

Chung, 2003, CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism, J Immunol, 170, 1958, 10.4049/jimmunol.170.4.1958

Johnson, 2004, Interleukin-11 and IL-17 and the pathogenesis of periodontal disease, J Periodontol, 75, 37, 10.1902/jop.2004.75.1.37

Tartour, 1999, Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, Cancer Res, 59, 3698

Numasaki, 2003, Interleukin-17 promotes angiogenesis and tumor growth, Blood, 101, 2620, 10.1182/blood-2002-05-1461

Benchetrit, 2002, Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism, Blood, 99, 2114, 10.1182/blood.V99.6.2114

Hirahara, 2000, Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene, Anticancer Res, 20, 3137

Kato, 2001, Expression of IL-17 mRNA in ovarian cancer, Biochem Biophys Res Commun, 282, 735, 10.1006/bbrc.2001.4618

Steiner, 2003, Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate, Prostate, 56, 171, 10.1002/pros.10238

Ciree, 2004, Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome), Int J Cancer, 112, 113, 10.1002/ijc.20373

Wrobel, 2003, Interleukin-17 in acute myeloid leukemia, J Cell Mol Med, 7, 472, 10.1111/j.1582-4934.2003.tb00250.x

Numasaki, 2005, IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis, J Immunol, 175, 6177, 10.4049/jimmunol.175.9.6177

Grazia Roncarolo, 2006, Interleukin-10-secreting type 1 regulatory T cells in rodents and humans, Immunol Rev, 212, 28, 10.1111/j.0105-2896.2006.00420.x

Weiner, 2001, Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells, Immunol Rev, 182, 207, 10.1034/j.1600-065X.2001.1820117.x

Lu, 2006, The immunoregulatory effects of Qa-1, Immunol Rev, 212, 51, 10.1111/j.0105-2896.2006.00418.x

Cortesini, 2001, CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity, Immunol Rev, 182, 201, 10.1034/j.1600-065X.2001.1820116.x

Rifa'i, 2004, Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis, J Exp Med, 200, 1123, 10.1084/jem.20040395

Hanninen, 2000, Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model, Immunol Rev, 173, 109, 10.1034/j.1600-065X.2000.917303.x

Zhang, 2006, The regulatory effect of natural killer cells: do ‘NK-reg cells’ exist?, Cell Mol Immunol, 3, 241

Yu, 2006, NK cells promote transplant tolerance by killing donor antigen-presenting cells, J Exp Med, 203, 1851, 10.1084/jem.20060603

Ochando, 2006, Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts, Nat Immunol, 7, 652, 10.1038/ni1333

Ariel, 2006, Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression, Nat Immunol, 7, 1209, 10.1038/ni1392

Liu, 2004, Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection, Transpl Immunol, 13, 239, 10.1016/j.trim.2004.10.006

Suciu-Foca, 2005, Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review, Int Immunopharmacol, 5, 7, 10.1016/j.intimp.2004.09.003

Liu, 1998, Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+, Int Immunol, 10, 775, 10.1093/intimm/10.6.775

Kapp, 2006, TCR transgenic CD8+ T cells activated in the presence of TGF{beta} express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection, Int Immunol, 18, 1549, 10.1093/intimm/dxl088

Zhang, 2001, CD3+CD4-CD8- alphabeta-TCR+ T cell as immune regulatory cell, J Mol Med, 79, 419, 10.1007/s001090100238

Zhang, 2000, Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat Med, 6, 782, 10.1038/77513

Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol, 155, 1151

Sakaguchi, 1996, T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases, J Autoimmun, 9, 211, 10.1006/jaut.1996.0026

Chatila, 2000, JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome, J Clin Invest, 106, R75, 10.1172/JCI11679

Wildin, 2001, X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy, Nat Genet, 27, 18, 10.1038/83707

Dieckmann, 2001, Ex vivo isolation and characterization of CD4(+) CD25(+) T cells with regulatory properties from human blood, J Exp Med, 193, 1303, 10.1084/jem.193.11.1303

Jonuleit, 2001, Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood, J Exp Med, 193, 1285, 10.1084/jem.193.11.1285

Thornton, 1998, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, J Exp Med, 188, 287, 10.1084/jem.188.2.287

Wing, 2003, CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells, Eur J Immunol, 33, 579, 10.1002/eji.200323701

Baecher-Allan, 2006, Human regulatory T cells and their role in autoimmune disease, Immunol Rev, 212, 203, 10.1111/j.0105-2896.2006.00417.x

Umetsu, 2006, The regulation of allergy and asthma, Immunol Rev, 212, 238, 10.1111/j.0105-2896.2006.00413.x

Rouse, 2006, Regulatory T cells in virus infections, Immunol Rev, 212, 272, 10.1111/j.0105-2896.2006.00412.x

Belkaid, 2006, Natural regulatory T cells and parasites: a common quest for host homeostasis, Immunol Rev, 212, 287, 10.1111/j.0105-2896.2006.00409.x

Waldmann, 2006, Infectious tolerance and the long-term acceptance of transplanted tissue, Immunol Rev, 212, 301, 10.1111/j.0105-2896.2006.00406.x

Izcue, 2006, Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation, Immunol Rev, 212, 256, 10.1111/j.0105-2896.2006.00423.x

Aluvihare, 2004, Regulatory T cells mediate maternal tolerance to the fetus, Nat Immunol, 5, 266, 10.1038/ni1037

Edinger, 2003, CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation, Nat Med, 9, 1144, 10.1038/nm915

Hoffmann, 2002, Donor-type CD4(+) CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation, J Exp Med, 196, 389, 10.1084/jem.20020399

Graca, 2002, Both CD4(+) CD25(+) and CD4(+) CD25(-) regulatory cells mediate dominant transplantation tolerance, J Immunol, 168, 5558, 10.4049/jimmunol.168.11.5558

Game, 2003, CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients, J Am Soc Nephrol, 14, 1652, 10.1097/01.ASN.0000067411.03024.A9

Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490

Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat Immunol, 4, 330, 10.1038/ni904

Khattri, 2003, An essential role for Scurfin in CD4+CD25+ T regulatory cells, Nat Immunol, 4, 337, 10.1038/ni909

Fontenot, 2005, Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity, 22, 329, 10.1016/j.immuni.2005.01.016

Ziegler, 2006, FOXP3: of mice and men, Annu Rev Immunol, 24, 209, 10.1146/annurev.immunol.24.021605.090547

Walker, 2003, Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+, J Clin Invest, 112, 1437, 10.1172/JCI19441

Gavin, 2006, Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development, Proc Natl Acad Sci U S A, 103, 6659, 10.1073/pnas.0509484103

Liu, 2006, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, 203, 1701, 10.1084/jem.20060772

Piccirillo, 2001, Cutting edge. control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells, J Immunol, 167, 1137, 10.4049/jimmunol.167.3.1137

Takahashi, 1998, Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int Immunol, 10, 1969, 10.1093/intimm/10.12.1969

Romagnoli, 2002, Preferential recognition of self antigens despite normal thymic deletion of CD4(+) CD25(+) regulatory T cells, J Immunol, 168, 1644, 10.4049/jimmunol.168.4.1644

Jordan, 2001, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide, Nat Immunol, 2, 301, 10.1038/86302

Cozzo, 2003, Cutting edge. self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells, J Immunol, 171, 5678, 10.4049/jimmunol.171.11.5678

Gavin, 2002, Homeostasis and anergy of CD4(+) CD25(+) suppressor T cells in vivo, Nat Immunol, 3, 33, 10.1038/ni743

Fisson, 2003, Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state, J Exp Med, 198, 737, 10.1084/jem.20030686

Ng, 2001, Human CD4(+) CD25(+) cells: a naturally occurring population of regulatory T cells, Blood, 98, 2736, 10.1182/blood.V98.9.2736

Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183

Thornton, 2004, Activation requirements for the induction of CD4+CD25+ T cell suppressor function, Eur J Immunol, 34, 366, 10.1002/eji.200324455

Dieckmann, 2002, Human CD4(+) CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected], J Exp Med, 196, 247, 10.1084/jem.20020642

Longhi, 2006, Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis, J Immunol, 176, 4484, 10.4049/jimmunol.176.7.4484

Nakamura, 2004, TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice, J Immunol, 172, 834, 10.4049/jimmunol.172.2.834

Nakamura, 2001, Cell contact-dependent immunosuppression by CD4(+) CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J Exp Med, 194, 629, 10.1084/jem.194.5.629

Ly, 2006, Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells, J Immunol, 177, 3695, 10.4049/jimmunol.177.6.3695

Lu, 2006, Mast cells are essential intermediaries in regulatory T-cell tolerance, Nature, 442, 997, 10.1038/nature05010

Duthoit, 2005, Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes, J Immunol, 174, 155, 10.4049/jimmunol.174.1.155

Duthoit, 2004, Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells, J Immunol, 172, 2238, 10.4049/jimmunol.172.4.2238

Sawitzki, 2005, IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo, J Exp Med, 201, 1925, 10.1084/jem.20050419

Takahashi, 2000, Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4, J Exp Med, 192, 303, 10.1084/jem.192.2.303

Read, 2006, Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo, J Immunol, 177, 4376, 10.4049/jimmunol.177.7.4376

Read, 2000, Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+) CD4(+) regulatory cells that control intestinal inflammation, J Exp Med, 192, 295, 10.1084/jem.192.2.295

Jago, 2004, Differential expression of CTLA-4 among T cell subsets, Clin Exp Immunol, 136, 463, 10.1111/j.1365-2249.2004.02478.x

Levings, 2001, Human CD25(+) CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function, J Exp Med, 193, 1295, 10.1084/jem.193.11.1295

Sansom, 2006, The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology, Immunol Rev, 212, 131, 10.1111/j.0105-2896.2006.00419.x

Kawahata, 2002, Generation of CD4(+) CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression, J Immunol, 168, 4399, 10.4049/jimmunol.168.9.4399

Pennington, 2006, Early events in the thymus affect the balance of effector and regulatory T cells, Nature, 444, 1073, 10.1038/nature06051

Tellier, 2006, An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes, Int Immunol, 18, 1509, 10.1093/intimm/dxl084

Bayer, 2005, Essential role for interleukin-2 for CD4(+) CD25(+) T regulatory cell development during the neonatal period, J Exp Med, 201, 769, 10.1084/jem.20041179

Tang, 2003, Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells, J Immunol, 171, 3348, 10.4049/jimmunol.171.7.3348

Kirk, 2006, Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab, Am J Transplant, 6, 1084, 10.1111/j.1600-6143.2006.01258.x

Coles, 1999, Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis, Lancet, 354, 1691, 10.1016/S0140-6736(99)02429-0

Hakim, 2005, Age-dependent incidence, time course, and consequences of thymic renewal in adults, J Clin Invest, 115, 930, 10.1172/JCI200522492

Mackall, 1997, Thymic aging and T-cell regeneration, Immunol Rev, 160, 91, 10.1111/j.1600-065X.1997.tb01030.x

Zhang, 2005, Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells, Nat Med, 11, 1238, 10.1038/nm1312

McHugh, 2002, Cutting edge. depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease, J Immunol, 168, 5979, 10.4049/jimmunol.168.12.5979

Barthlott, 2003, T cell regulation as a side effect of homeostasis and competition, J Exp Med, 197, 451, 10.1084/jem.20021387

Curotto de Lafaille, 2004, CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion, J Immunol, 173, 7259, 10.4049/jimmunol.173.12.7259

Liang, 2005, Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus, J Exp Med, 201, 127, 10.1084/jem.20041201

Almeida, 2006, Competition controls the rate of transition between the peripheral pools of CD4+, Int Immunol, 18, 1607, 10.1093/intimm/dxl093

Almeida, 2006, Indexation as a novel mechanism of lymphocyte homeostasis. the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells, J Immunol, 177, 192, 10.4049/jimmunol.177.1.192

Vukmanovic-Stejic, 2006, Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo, J Clin Invest, 116, 2423, 10.1172/JCI28941

Yu, 2006, Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells, J Immunol, 177, 5115, 10.4049/jimmunol.177.8.5115

Malek, 2004, Tolerance, not immunity, crucially depends on IL-2, Nat Rev Immunol, 4, 665, 10.1038/nri1435

Knoechel, 2005, Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen, J Exp Med, 202, 1375, 10.1084/jem.20050855

Thorstenson, 2001, Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen, J Immunol, 167, 188, 10.4049/jimmunol.167.1.188

Apostolou, 2004, In vivo instruction of suppressor commitment in naive T cells, J Exp Med, 199, 1401, 10.1084/jem.20040249

Kretschmer, 2005, Inducing and expanding regulatory T cell populations by foreign antigen, Nat Immunol, 6, 1219, 10.1038/ni1265

Grimbert, 2006, Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+, J Immunol, 177, 3534, 10.4049/jimmunol.177.6.3534

Huber, 2004, Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells, J Immunol, 173, 6526, 10.4049/jimmunol.173.11.6526

Schramm, 2004, TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo, Int Immunol, 16, 1241, 10.1093/intimm/dxh126

Marie, 2005, TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J Exp Med, 201, 1061, 10.1084/jem.20042276

Chen, 2003, Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152

Fantini, 2004, Cutting edge: TGF-beta induces a regulatory phenotype in CD4+, J Immunol, 172, 5149, 10.4049/jimmunol.172.9.5149

Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4

Trinchieri, 2003, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat Rev Immunol, 3, 133, 10.1038/nri1001

Leonard, 1995, Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12, J Exp Med, 181, 381, 10.1084/jem.181.1.381

Constantinescu, 1998, Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis, J Immunol, 161, 5097

Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355

Murphy, 2003, Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, J Exp Med, 198, 1951, 10.1084/jem.20030896

Aggarwal, 2003, Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17, J Biol Chem, 278, 1910, 10.1074/jbc.M207577200

Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254

Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat Immunol, 6, 1133, 10.1038/ni1261

Ottenhoff, 2002, Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae, Nat Genet, 32, 97, 10.1038/ng0902-97

Verreck, 2004, Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria, Proc Natl Acad Sci USA, 101, 4560, 10.1073/pnas.0400983101

Uhlig, 2006, Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology, Immunity, 25, 309, 10.1016/j.immuni.2006.05.017

Parham, 2002, A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R, J Immunol, 168, 5699, 10.4049/jimmunol.168.11.5699

Hoeve, 2006, Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells, Eur J Immunol, 36, 661, 10.1002/eji.200535239

Rangachari, 2006, T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17, J Exp Med, 203, 2009, 10.1084/jem.20052222